Slate Run Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SLATE RUN PHARMA, and what generic and branded alternatives to SLATE RUN PHARMA drugs are available?
SLATE RUN PHARMA has seventeen approved drugs.
Drugs and US Patents for Slate Run Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Slate Run Pharma | PROMETHAZINE DM | dextromethorphan hydrobromide; promethazine hydrochloride | SYRUP;ORAL | 040649-001 | Feb 14, 2006 | AA | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Slate Run Pharma | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 212091-003 | Dec 28, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Slate Run Pharma | BIVALIRUDIN | bivalirudin | INJECTABLE;INTRAVENOUS | 213078-001 | May 28, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.